Aadi Bioscience, Inc. (AADI)
NASDAQ: AADI · Real-Time Price · USD
2.400
+0.040 (1.69%)
Dec 3, 2024, 1:34 PM EST - Market open
Aadi Bioscience Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Aadi Bioscience stock has a target of 1.75, which predicts a decrease of -27.08% from the current stock price of 2.40.
Analyst Consensus: Hold
* Price targets were last updated on Aug 27, 2024.
Analyst Ratings
The average analyst rating for AADI stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $5 → $1.75 | Buy → Hold | Downgrades | $5 → $1.75 | -27.08% | Aug 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 21, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 14, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $5 | Buy | Maintains | $30 → $5 | +108.33% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
26.64M
from 24.35M
Increased by 9.39%
Revenue Next Year
28.28M
from 26.64M
Increased by 6.15%
EPS This Year
-1.96
from -2.44
EPS Next Year
-0.47
from -1.96
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 27.6M | 29.1M | 33.4M | |||
| Avg | 26.6M | 28.3M | 31.5M | |||
| Low | 25.4M | 27.1M | 29.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 13.4% | 9.4% | 18.0% | |||
| Avg | 9.4% | 6.1% | 11.2% | |||
| Low | 4.4% | 1.9% | 3.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.98 | -0.32 | -0.27 | |||
| Avg | -1.96 | -0.47 | -0.33 | |||
| Low | -1.92 | -0.62 | -0.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.